Concepedia

Author

Lenka Sedlaříková

Masaryk UniversityORCID

Also Known As

L Sedlarikova, L. Sedlarikova, Lenka Sedlarikova, Lenka Sedlaříková, Vlasta Sýkorová

67

Publications

1.4K

Citations

15

H-Index

10

Concepts

All Affiliations

Masaryk UniversityUniversity Hospital BrnoUniversity Hospital OstravaUniversity of OstravaCentral European Institute of Technology – Masaryk University
LS

About

Lenka Sedlaříková is an author at Masaryk University specializing in tumor biology, cancer research, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

67

2

Immunology

2

2

67

3

Pathology

2

2

67

4

Hematology

2

2

67

5

Autoimmune Disease

1

1

22

Lenka Sedlaříková

×

11

Publications

441

Citations

11

H-Index

YearCitations

Standardization of Sequencing Coverage Depth in NGS: Recommendation for Detection of Clonal and Subclonal Mutations in Cancer Diagnostics

Anna Petráčková, Michal Vašínek, Lenka Sedlaříková,

Frontiers in Oncology

2019

128

Cytogenetics in multiple myeloma patients progressing into extramedullary disease

Lenka Bešše, Lenka Sedlaříková, Henrieta Grešlíková,

European Journal Of Haematology

2015

55

Circulating exosomal long noncoding RNA PRINS—First findings in monoclonal gammopathies

Lenka Sedlaříková, Božena Bollová, Lenka Radová,

Hematological Oncology

2018

51

Deregulated expression of long non‐coding <scp>RNA UCA</scp>1 in multiple myeloma

Lenka Sedlaříková, Barbora Gromesová, Veronika Kubaczková,

European Journal Of Haematology

2017

48

Serum miR-29a as a marker of multiple myeloma

Sabina Ševčı́ková, Lenka Kubiczková, Lenka Sedlaříková,

Leukemia & lymphoma/Leukemia and lymphoma

2012

45

Dynamics of tumor‐specific cfDNA in response to therapy in multiple myeloma patients

Dávid Vrábel, Lenka Sedlaříková, Lenka Bešše,

European Journal Of Haematology

2019

33

Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma

Lenka Bešše, Lenka Sedlaříková, Fedor Kryukov,

PLoS ONE

2015

22

Registry of Monoclonal Gammopathies (RMG) in the Czech Republic

Jakub Radocha, Luděk Pour, Ivan Špıčka,

Blood

2015

17

Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data

Sabina Ševčı́ková, Helena Paszeková, Lenka Bešše,

Biomedical Papers

2015

15

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus ( <scp>HIV</scp> )‐protease inhibitors lopinavir or nelfinavir

Dominik Abt, Andrej Bešše, Lenka Sedlaříková,

British Journal of Urology

2017

14

Page 1